Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | -15.2 | -22.4 | -7.01 | -1.58 | -4.00 | -1.70 | ||
Changes by years, y/y, % | +397% | +47% | -69% | -77% | +153% | +5.5% |
Iovance Biotherapeutics. EV/EBITDA
Iovance Biotherapeutics. EV/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EV/EBITDA | ? | -1.85 | -3.29 | -1.87 | -4.16 | -8.20 | -1.70 | |
Changes by years, y/y, % | -71% | -16% | -43% | +143% | +345% | |||
Changes by quarters, q/q, % | +8% | +78% | -43% | +122% | +97% |